Retraction: Interfering HMGB3 release from cancer-associated fibroblasts by miR-200b represses chemoresistance and epithelial-mesenchymal transition of gastric cancer cells
Retraction to: J Gastrointest Oncol 2022;13:2197-218
The article “Interfering HMGB3 release from cancer-associated fibroblasts by miR-200b represses chemoresistance and epithelial-mesenchymal transition of gastric cancer cells” (doi: 10.21037/jgo-22-723) (1), published in Journal of Gastrointestinal Oncology, Vol. 13. No. 5 (October 2022), has been retracted at the request of all authors.W
Following a subsequent in-depth review and verification of the original data, the authors identified fundamental flaws in the key data and analytical processes of the study, which led to the unreliability of the main conclusions. To maintain the integrity and scientific rigor of the academic record and prevent misleading subsequent research, the authors have unanimously agreed to voluntarily retract this article.
Footnote
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jgo.amegroups.com/article/view/10.21037/jgo-20262-01/coif). The authors have no conflicts of interest to declare.
Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
References
- Ke Y, Mai J, Liu Z, et al. Interfering HMGB3 release from cancer-associated fibroblasts by miR-200b represses chemoresistance and epithelial-mesenchymal transition of gastric cancer cells. J Gastrointest Oncol 2022;13:2197-218. [Crossref] [PubMed]
